Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy

BACKGROUND: Panax notoginseng triol saponins (PTS) has been used clinically for ischemic stroke therapy (IST) in China for more than 17 years due to its anti-platelet aggregation and neuro-protective effects, but its mechanism of action is not fully understand. In this study, anti-platelet aggregati...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhi-yi, Xu, Yang, Xie, Xiao-fang, Tian, Yin, Sui, Jun-hui, Sun, Yong, Lin, Da-sheng, Gao, Xing, Peng, Cheng, Fan, Yu-jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816336/
https://www.ncbi.nlm.nih.gov/pubmed/33468191
http://dx.doi.org/10.1186/s13020-021-00424-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816336/
https://www.ncbi.nlm.nih.gov/pubmed/33468191
http://dx.doi.org/10.1186/s13020-021-00424-3

Ejemplares similares